Given the important role of JNK/NF-κB in AML cells, we proposed a novel insight that Nrf2 overexpression may hinder RFC4 expression by activating the JNK/NF-κB signaling pathway in THP-1, U937 and MV4-11 cells. Here, MAPK8 is linked to acute myeloid leukemia.